PDF(Pubmed)
Abstract：
BACKGROUND: The integrated care pathways for atopic dermatitis (AD-ICPs) aim to bridge the gap between existing AD treatment evidence-based guidelines and expert opinion based on daily practice by offering a structured multidisciplinary plan for patient management of AD. ICPs have the potential to enhance guideline recommendations by combining interventions and aspects from different guidelines, integrating quality assurance, and describing co-ordination of care. Most importantly, patients can enter the ICPs at any level depending on AD severity, resources available in their country, and economic factors such as differences in insurance reimbursement systems.
METHODS: The GA2 LEN ADCARE network and partners as well as all stakeholders, abbreviated as the AD-ICPs working group, were involved in the discussion and preparation of the AD ICPs during a series of subgroup workshops and meetings in years 2020 and 2021, after which the document was circulated within all GAL2 EN ADCARE centres.
RESULTS: The AD-ICPs outline the diagnostic procedures, possible co-morbidities, different available treatment options including differential approaches for the pediatric population, and the role of the pharmacists and other stakeholders, as well as remaining unmet needs in the management of AD.
CONCLUSIONS: The AD-ICPs provide a multidisciplinary plan for improved diagnosis, treatment, and patient feedback in AD management, as well as addressing critical unmet needs, including improved access to care, training specialists, implementation of educational programs, assessment on the impact of climate change, and fostering a personalised treatment approach. By focusing on these key areas, the initiative aims to pave the way for a brighter future in the management of AD.
METHODS: The GA2 LEN ADCARE network and partners as well as all stakeholders, abbreviated as the AD-ICPs working group, were involved in the discussion and preparation of the AD ICPs during a series of subgroup workshops and meetings in years 2020 and 2021, after which the document was circulated within all GAL2 EN ADCARE centres.
RESULTS: The AD-ICPs outline the diagnostic procedures, possible co-morbidities, different available treatment options including differential approaches for the pediatric population, and the role of the pharmacists and other stakeholders, as well as remaining unmet needs in the management of AD.
CONCLUSIONS: The AD-ICPs provide a multidisciplinary plan for improved diagnosis, treatment, and patient feedback in AD management, as well as addressing critical unmet needs, including improved access to care, training specialists, implementation of educational programs, assessment on the impact of climate change, and fostering a personalised treatment approach. By focusing on these key areas, the initiative aims to pave the way for a brighter future in the management of AD.
摘要：
背景：特应性皮炎综合治疗途径（AD-ICPs）旨在通过为患者管理AD提供结构化的多学科计划，弥合现有的基于证据的AD治疗指南与基于日常实践的专家意见之间的差距。ICPs有可能通过结合不同指南的干预措施和方面来增强指南建议，整合质量保证，并描述护理协调。最重要的是,患者可以根据AD的严重程度进入任何水平的ICP，他们国家的可用资源，和经济因素，如保险报销制度的差异。
方法：GA2LENADCARE网络和合作伙伴以及所有利益相关者，缩写为AD-ICPs工作组，在2020年和2021年的一系列分组研讨会和会议期间，参与了ADICPs的讨论和准备工作，之后该文件在所有GAL2ENADCARE中心分发。
结果：AD-ICP概述了诊断程序，可能的合并症，不同的可用治疗方案，包括针对儿科人群的不同方法，以及药剂师和其他利益相关者的角色，以及AD管理中仍未满足的需求。
结论：AD-ICP为改善诊断提供了多学科计划，治疗,和患者在AD管理中的反馈，以及解决关键的未满足需求，包括改善获得护理的机会，培训专家实施教育计划，评估气候变化的影响，培养个性化的治疗方法。通过关注这些关键领域，该计划旨在为AD管理的美好未来铺平道路。
方法：GA2LENADCARE网络和合作伙伴以及所有利益相关者，缩写为AD-ICPs工作组，在2020年和2021年的一系列分组研讨会和会议期间，参与了ADICPs的讨论和准备工作，之后该文件在所有GAL2ENADCARE中心分发。
结果：AD-ICP概述了诊断程序，可能的合并症，不同的可用治疗方案，包括针对儿科人群的不同方法，以及药剂师和其他利益相关者的角色，以及AD管理中仍未满足的需求。
结论：AD-ICP为改善诊断提供了多学科计划，治疗,和患者在AD管理中的反馈，以及解决关键的未满足需求，包括改善获得护理的机会，培训专家实施教育计划，评估气候变化的影响，培养个性化的治疗方法。通过关注这些关键领域，该计划旨在为AD管理的美好未来铺平道路。
